Fonte: Clinical Chemistry. Nome do evento: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Assuntos: DIABETES MELLITUS, EXPRESSÃO GÊNICA
ABNT
HIRATA, Mario Hiroyuki et al. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. 2009, Anais.. Chicago: American Association for Clinical Chemistry, 2009. p. A223 res. E-41. . Acesso em: 01 nov. 2024.APA
Hirata, M. H., Himelfarb, S. T., Marques, M. F. dos S. F., Silva, F. A., Rodrigues, A. C., Sampaio, M. P., et al. (2009). Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. In Clinical Chemistry (Vol. 55, p. A223 res. E-41). Chicago: American Association for Clinical Chemistry.NLM
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 nov. 01 ]Vancouver
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 nov. 01 ]